Depletion of CD8+ T cells led to the loss of anti-tumor effects mediated by the combination therapy, whereas depletion of CD4+ T cells led to a decrease in tumor growth compared to mice treated with IL PV-10 in combination with anti-PD-1 antibodies and control NrIgG. The gene discussed is PDCD1; the disease is neoplasm.